Biohaven's CEO recaps last week's R&D Day and walks us through the company's pipeline
- blonca9
- Jun 6, 2024
- 1 min read
From the NYSE, Vlad Coric covers programs including protein degradation, ADCs, myostatin inhibition, the ion channel programs, and neuroinflammation.